Come up with a name for your new list and we'll add to it:
Sollis Therapeutics raised a round of funding on December 08, 2017. Investors include
Ohio Third Frontier Commission.
Sollis Therapeutics is a clinical-stage biotechnology company focused on developing novel non-steroid, non-opioid analgesics. The company's first product is an extended release combination analgesic a…